Neopenda cover feature

Neopenda

Neopenda is innovating medical technologies for high-growth emerging markets
$258,475 Raised
Ended January 19th
610 Investors

Deal highlights

  • Medical device company with potential to save up to 2.6M newborn lives a year in emerging economies
  • $7.1B target market by 2023: Medical devices in Africa

  • Patent pending and additional provisional patents filed

  • Founders are biomedical engineers out of Columbia University

  • Techstars Chicago Class of 2018

  • $770k raised to date from Columbia University, Cisco, Vodafone, ADAP Capital, Techstars, and others

  • A for-profit Public Benefit Corporation

  • Become part of Neopenda’s journey for as little as $100, and see how a little goes a long way in saving lives

We Are Neopenda.

Our name comes from “neo” - for neonates, and “penda” - Swahili for love. 

Preventable Newborn Mortality: 3 million newborns are lost in developing countries each year

In fact, a newborn born in a developing country like Uganda has a nine times poorer chance of surviving its first month than one born in the United States.

It doesn’t have to be this way. WHO data shows that 80% of newborn deaths are preventable. The primary causes are complications of preterm birth, birth asphyxia, and infections. Although these conditions are treatable, many newborns do not receive the attention they need because facilities are overcrowded, understaffed, and ill-equipped. Nurses in these facilities don’t have the tools they need to provide high quality neonatal care. As a result...

Learn more about this company

Financials

Most recent Fiscal Year

Income Statement

Revenue
18%
$158,745
Cost of Goods Sold
$0
Gross Profit
18%
$158,745
Taxes
$0
Net Income
83%
$2,730

Balance Sheet

Total Assets
1%
$37,367
Cash
1%
$37,354
Accounts Receivable
$0
Short Term Debt
$0
Long Term Debt
$0

Other popular startups

Get email updates for the latest investment opportunities
Email
Email